Bone fractures and incident epithelial ovarian cancer in a prospective cohort study
- PMID: 19951211
- PMCID: PMC2828254
- DOI: 10.1089/jwh.2008.1341
Bone fractures and incident epithelial ovarian cancer in a prospective cohort study
Abstract
Objective: Osteoporosis and osteoporotic fractures are hypothesized to reflect circulating hormone levels in older women and have been inversely associated with breast and endometrial cancers. However, associations between fractures and ovarian cancer, another hormonal cancer, have not been examined. Therefore, we conducted a prospective study among women in the Breast Cancer Detection Demonstration Project Follow-up Study.
Methods: Fractures after age 45 were assessed using two questionnaires from 1987 to 1995. Relative risks (RRs) and 95% confidence intervals (CIs) were estimated by Cox proportional hazards models, adjusting for potential confounders. Fracture location was used to further evaluate the fractures most likely to be osteoporotic.
Results: Among 36,115 women with up to 11 years of follow-up (average follow-up was 8.3 years), there were 151 cases of incident ovarian cancer. Fractures were reported by 19% (n = 6,919) of women. Ovarian cancer risk was not associated with any (RR = 1.13, 95% CI 0.74-1.71) or likely osteoporotic (RR = 1.05, 95% CI 0.65-1.69) fractures. Among never users of postmenopausal hormones, the association between any fracture and ovarian cancer (RR = 1.21, 95% CI 0.55-2.65, n = 50 cases) also was statistically nonsignificant.
Conclusions: Data from this large, prospective study do not support an association between fractures and ovarian cancer risk.
Similar articles
-
Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2000-5. doi: 10.1158/1055-9965.EPI-12-0867. Epub 2012 Aug 31. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22941335
-
Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study.J Public Health Med. 2000 Jun;22(2):155-60. doi: 10.1093/pubmed/22.2.155. J Public Health Med. 2000. PMID: 10912553
-
Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.Arch Intern Med. 2005 Mar 14;165(5):552-8. doi: 10.1001/archinte.165.5.552. Arch Intern Med. 2005. PMID: 15767532
-
Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.Menopause Int. 2007 Sep;13(3):110-5. doi: 10.1258/175404507781605668. Menopause Int. 2007. PMID: 17785036
-
Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort.J Natl Cancer Inst. 2004 Mar 3;96(5):396-402. doi: 10.1093/jnci/djh061. J Natl Cancer Inst. 2004. PMID: 14996861
Cited by
-
Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older.J Natl Cancer Inst. 2022 Jun 13;114(6):878-884. doi: 10.1093/jnci/djac050. J Natl Cancer Inst. 2022. PMID: 35262727 Free PMC article.
-
Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis.JNCI Cancer Spectr. 2018 Jan;2(1):pky001. doi: 10.1093/jncics/pky001. Epub 2018 Mar 21. JNCI Cancer Spectr. 2018. PMID: 31355356 Free PMC article.
-
Exploring estrogen-related mechanisms in ovarian carcinogenesis: association between bone mineral density and ovarian cancer risk in a multivariable Mendelian randomization study.Cancer Causes Control. 2025 Feb;36(2):171-182. doi: 10.1007/s10552-024-01926-9. Epub 2024 Oct 18. Cancer Causes Control. 2025. PMID: 39419895 Free PMC article.
References
-
- Olsen CM. Green AC. Whiteman DC. Sadeghi S. Kolahdooz F. Webb PM. Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis. Eur J Cancer. 2007;43:690–709. - PubMed
-
- Lukanova A. Kaaks R. Endogenous hormones and ovarian cancer: Epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 2005;14:98–107. - PubMed
-
- Lukanova A. Lundin E. Akhmedkhanov A, et al. Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer. 2003;104:636–642. - PubMed
-
- Helzlsouer KJ. Alberg AJ. Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA. 1995;274:1926–1930. - PubMed
-
- Key TJ. Verkasalo PK. Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2:133–140. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical